Artemis Therapeutics (OTCMKTS:ATMS) Stock Price Down 13.7%

Artemis Therapeutics Inc (OTCMKTS:ATMS)’s share price traded down 13.7% during mid-day trading on Friday . The stock traded as low as $0.15 and last traded at $0.15, 4,126 shares changed hands during trading. An increase of 2,026% from the average session volume of 194 shares. The stock had previously closed at $0.18.

The company has a 50-day moving average of $0.17 and a 200-day moving average of $0.23.

Artemis Therapeutics Company Profile (OTCMKTS:ATMS)

Artemis Therapeutics Inc, a biopharmaceutical company, engages in the development of agents for the prevention and treatment of severe and life-threatening infectious diseases. The company's lead product candidate is Artemisone, an orally-administered 10-alpha-amino artemisinin derivative with antiviral and antiparasitic properties.

See Also: What are the benefits of a balanced fund?

Receive News & Ratings for Artemis Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Artemis Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.